Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Borrelia burgdorferi is a species of spirochete bacteria and the primary causative agent of Lyme disease in humans. It is transmitted to humans through the bite of infected blacklegged ticks (genus Ixodes). Infection leads to multi-stage illness if untreated, beginning with localized skin lesions progressing potentially toward systemic involvement affecting joints, heart, and the nervous system. The pathology results primarily from host immune responses rather than classical bacterial toxins.
Antibiotics inhibit bacterial growth by targeting essential bacterial processes such as cell wall synthesis or protein synthesis.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Borrelia burgdorferi (Bb).